The mission of the UW/FHCRC CFAR Developmental Core is to create a generation of young, innovative, interdisciplinary HIV/AIDS researchers and to foster collaboration among UW/FHCRC CFAR investigators. This mission is articulated through three specific aims, the first of which is to provide research support and mentoring to junior investigators at institutions affiliated with the UW/FHCRC CFAR. Our New Investigator Awards (NIAs), which have successfully fostered the careers of 62 HIV/AIDS investigators since the program's beginning, will continue with modifications to prioritize applications in areas of importance to CFAR's Strategic Research priorities each year and further enhance mentorship through facilitated interawardee networking. Trainee Support Grants (TSGs) used to promote new collaborations will be continued. Additionally, the Core coordinates and collaborates with other CFAR Cores for more specialized developmental award programs, including International Pilot Awards (International Core) and HIV-Associated Malignancy Awards (AIDS-Associated Infections and Malignancies Core);and with OAR, IAS, two other CFARS, and NIH for the Creative and Novel Ideas in HIV Research (CNIHR) program.
The second aim i s to enhance career development, communication among investigators, and multidisciplinary research by sponsoring an annual UW/FHCRC CFAR Symposium.
The third aim i s to provide initial support for HIV/AIDS research in important new research areas (Emerging Opportunity Grants [EOGs]). Innovative aspects of this proposal include enhancing mentorship, a proposed collaboration with the International Core for a Mentored International Investigator Award (MHA), holding a Mock """"""""Study Section"""""""" (MSS) for NIA applicants to enhance grant-writing skills, holding a Junior Investigator Poster Session (JIPS) at the annual Symposium, and improved methods for pre- and post-award tracking. The Developmental Core will collaborate with all other CFAR cores and working groups, other CFARS, and research entities such as the UW CTSA;and has specific policies, procedures, and measurable value-added indicators for each core activity. This Core's activities will provide value to the UW/FHCRC and national HIV/AIDS research communities by fostering innovative, interdisciplinary, collaborative HIV/AIDS research now and in the future.

Public Health Relevance

This project will provide support to help young scientists have successful careers as HIV researchers, help UW/FHCRC researchers and researchers communicate and better work together, and fund innovative HIV/AIDS research. The projects and investigators supported by the Core will provide new knowledge about how to prevent HIV infection, how HIV makes people sick, how to treat and eventually cure HIV, and how to decrease HIV-related inequalities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027757-27S1
Application #
8910998
Study Section
Special Emphasis Panel (ZAI1-UKS-A)
Program Officer
Namkung, Ann S
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
27
Fiscal Year
2014
Total Cost
$742,010
Indirect Cost
$170,479
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399
Golovaty, Ilya; Sharma, Monisha; Van Heerden, Alastair et al. (2018) Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr 78:522-526
LaCourse, Sylvia M; Cranmer, Lisa M; Njuguna, Irene N et al. (2018) Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children. Clin Infect Dis 66:1798-1801
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32:583-593
Ross, Jennifer M; Ying, Roger; Celum, Connie L et al. (2018) Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs. Epidemics 23:34-41
Patel, Rena C; Bukusi, Elizabeth A; Baeten, Jared M (2018) Current and future contraceptive options for women living with HIV. Expert Opin Pharmacother 19:1-12
Stekler, Joanne D; Milne, Ross; Payant, Rachel et al. (2018) Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. PLoS Med 15:e1002537
Wagner, Anjuli D; Shah, Seema K; Njuguna, Irene N et al. (2018) Financial Incentives to Motivate Pediatric HIV Testing-Assessing the Potential for Coercion, Inducement, and Voluntariness. J Acquir Immune Defic Syndr 78:e15-e18

Showing the most recent 10 out of 1275 publications